Evidence map›Paper›PMID 41369916›Full record

ArticleCurrent microbiology2025

Response of Ocular Bacteria Exposure to Cerium Oxide Nanoparticles in Eye Drop Formulation.

Nhung H A Nguyen, Marlita Marlita, Joana Ramis, Miguel A Gomez-Gonzalez, Miroslava Rysova, Anna Duarri, Victor F Puntes, Alena Sevcu

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nhung H A NguyenInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Bendlova 1409/7, Liberec, 461 17, Czech Republic. nhung.nguyen@tul.cz.
Marlita MarlitaInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Bendlova 1409/7, Liberec, 461 17, Czech Republic.
Joana RamisPharmacokinetic Nanoparticles, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
Miguel A Gomez-GonzalezDiamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, Oxfordshire, UK.
Miroslava RysovaInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Bendlova 1409/7, Liberec, 461 17, Czech Republic.
Anna DuarriOphthalmology Research Group, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
Victor F PuntesPharmacokinetic Nanoparticles, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
Alena SevcuInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Bendlova 1409/7, Liberec, 461 17, Czech Republic.

Funding

Instituto de Salud Carlos III (PI18/00219; LUCIA) and ERA-NET EuroNanoMed III-ISCIII (AC19/00080; CELLUX) AC19/00080
6 · The paper itself

Abstract

Cerium oxide nanoparticles (CeO

Indexed as

BacteriaCeriumEyeNanoparticlesOphthalmic SolutionsBacterial ProteinsHumansMicrobiotaRNA, Ribosomal, 16SBacterial Proteinsceric oxideCeriumOphthalmic SolutionsRNA, Ribosomal, 16S

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.